Skip to main content
. 2022 May 27;19(11):6522. doi: 10.3390/ijerph19116522

Table 1.

Methodological quality assessment using PEDro scale.

Study 1 2 3 4 5 6 7 8 9 10 11 Total Overall Quality
Paavolainen et al. [17] Y N N Y N N N Y Y N Y 4 Moderate
Hoff et al. [15] N Y N Y N N Y Y Y Y Y 7 High
Hoff et al. [13] Y Y N Y Y Y N Y Y Y Y 8 High
Østerås et al. [14] Y Y N Y N N N Y Y N Y 5 Moderate
Mikkola et al. [18] Y N N Y N N N Y Y Y Y 5 Moderate
Losnegard et al. [16] Y N N Y N N N Y Y Y Y 5 Moderate
Skattebo et al. [23] Y N N Y N N N Y Y Y Y 5 Moderate
Carlsson et al. [19] Y Y N Y N N N Y Y Y Y 6 High
Øfsteng et al. [24] Y N N Y N N N Y Y Y Y 5 Moderate
Vahtra et al. [25] Y N N Y N N N Y Y Y Y 5 Moderate
Mean - - - - - - - - - - - 5.5 Moderate
Median - - - - - - - - - - - 5 -

Y: yes, N: no. 1: Eligibility criteria were specified. 2: Subjects were randomly allocated to groups. 3: Allocation was concealed. 4: The groups were similar at baseline regarding the most important prognostic indicators. 5: There was blinding of all subjects. 6: There was blinding of all therapists/researchers who administered the therapy/protocol. 7: There was blinding of all assessors who measured at least one key outcome. 8: Measures of at least one key outcome were obtained from more than 85% of the subjects that were initially allocated to groups. 9: All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome were analyzed using “intention to treat”. 10: The results of between-group statistical comparisons were reported for at least one key outcome. 11: The study provided both point measures and measures of variability for at least one key outcome.